These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 21440630)

  • 101. 2-Arachidonylglycerol acting on CB1 cannabinoid receptors mediates delayed cardioprotection induced by nitric oxide in rat isolated hearts.
    Wagner JA; Abesser M; Harvey-White J; Ertl G
    J Cardiovasc Pharmacol; 2006 May; 47(5):650-5. PubMed ID: 16775503
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Dynamic changes to the endocannabinoid system in models of chronic pain.
    Rani Sagar D; Burston JJ; Woodhams SG; Chapman V
    Philos Trans R Soc Lond B Biol Sci; 2012 Dec; 367(1607):3300-11. PubMed ID: 23108548
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Attenuation of fear-conditioned analgesia in rats by monoacylglycerol lipase inhibition in the anterior cingulate cortex: Potential role for CB
    Corcoran L; Mattimoe D; Roche M; Finn DP
    Br J Pharmacol; 2020 May; 177(10):2240-2255. PubMed ID: 31967664
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Targeting 2-arachidonoylglycerol signalling in the neurobiology and treatment of depression.
    Silveira KM; Wegener G; Joca SRL
    Basic Clin Pharmacol Toxicol; 2021 Jul; 129(1):3-14. PubMed ID: 33905617
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Paradoxical effects of JZL184, an inhibitor of monoacylglycerol lipase, on bone remodelling in healthy and cancer-bearing mice.
    Marino S; de Ridder D; Bishop RT; Renema N; Ponzetti M; Sophocleous A; Capulli M; Aljeffery A; Carrasco G; Gens MD; Khogeer A; Ralston SH; Gertsch J; Lamoureux F; Heymann D; Rucci N; Idris AI
    EBioMedicine; 2019 Jun; 44():452-466. PubMed ID: 31151929
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Transient Cannabinoid Receptor 2 Blockade during Immunization Heightens Intensity and Breadth of Antigen-specific Antibody Responses in Young and Aged mice.
    Dotsey E; Ushach I; Pone E; Nakajima R; Jasinskas A; Argueta DA; Dillon A; DiPatrizio N; Davies H; Zlotnik A; Crompton PD; Felgner PL
    Sci Rep; 2017 Feb; 7():42584. PubMed ID: 28209996
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Involvement of leptin signaling in the development of cannabinoid CB2 receptor-dependent mirror image pain.
    Nozaki C; Nent E; Bilkei-Gorzo A; Zimmer A
    Sci Rep; 2018 Jul; 8(1):10827. PubMed ID: 30018366
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Systemic administration of Resolvin D1 reduces cancer-induced bone pain in mice: Lack of sex dependency in pain development and analgesia.
    Flippen A; Khasabova IA; Simone DA; Khasabov SG
    Cancer Med; 2024 Aug; 13(15):e70077. PubMed ID: 39101490
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Inhibition of DAGLβ as a therapeutic target for pain in sickle cell disease.
    Khasabova IA; Gable J; Johns M; Khasabov SG; Kalyuzhny AE; Golovko MY; Golovko SA; Kiven S; Gupta K; Seybold VS; Simone DA
    Haematologica; 2023 Mar; 108(3):859-869. PubMed ID: 35615929
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Chronic Administration of Cannabinoid Receptor 2 Agonist (JWH-133) Increases Ectopic Ovarian Tumor Growth and Endocannabinoids (Anandamide and 2-Arachidonoyl Glycerol) Levels in Immunocompromised SCID Female Mice.
    Blanton HL; McHann MC; De Selle H; Dancel CL; Redondo JL; Molehin D; German NA; Trasti S; Pruitt K; Castro-Piedras I; Guindon J
    Front Pharmacol; 2022; 13():823132. PubMed ID: 35242036
    [TBL] [Abstract][Full Text] [Related]  

  • 111. The endocannabinoid N-arachidonoyl dopamine is critical for hyperalgesia induced by chronic sleep disruption.
    Ding W; Yang L; Shi E; Kim B; Low S; Hu K; Gao L; Chen P; Ding W; Borsook D; Luo A; Choi JH; Wang C; Akeju O; Yang J; Ran C; Schreiber KL; Mao J; Chen Q; Feng G; Shen S
    Nat Commun; 2023 Oct; 14(1):6696. PubMed ID: 37880241
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Chiral Me-2-arachidonoyl Glycerols: The First Potent Endocannabinoid Glyceride Templates with Stability to COX-2.
    Nikas SP; Ji L; Liu Y; Georgiadis MO; Dopeshwarkar A; Straiker A; Kudalkar S; Sadybekov AV; Dvorakova M; Katritch V; Mackie K; Marnett L; Makriyannis A
    ACS Med Chem Lett; 2024 Jun; 15(6):965-971. PubMed ID: 38894922
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Alleviation of Neuropathology by Inhibition of Monoacylglycerol Lipase in APP Transgenic Mice Lacking CB2 Receptors.
    Zhang J; Chen C
    Mol Neurobiol; 2018 Jun; 55(6):4802-4810. PubMed ID: 28733897
    [TBL] [Abstract][Full Text] [Related]  

  • 114. CB2 Receptors and Neuron-Glia Interactions Modulate Neurotoxicity Generated by MAGL Inhibition.
    Rojo-Bustamante E; Íñigo-Marco I; Abellanas MA; Vinueza-Gavilanes R; Baltanás A; Luquin E; Arrasate M; Aymerich MS
    Biomolecules; 2020 Aug; 10(8):. PubMed ID: 32824740
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors.
    Mechoulam R; Ben-Shabat S; Hanus L; Ligumsky M; Kaminski NE; Schatz AR; Gopher A; Almog S; Martin BR; Compton DR
    Biochem Pharmacol; 1995 Jun; 50(1):83-90. PubMed ID: 7605349
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Cannabinoid CB
    Ivy D; Palese F; Vozella V; Fotio Y; Yalcin A; Ramirez G; Mears D; Wynn G; Piomelli D
    Neuropsychopharmacology; 2020 Jul; 45(8):1330-1338. PubMed ID: 32375160
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
    Guindon J; Lai Y; Takacs SM; Bradshaw HB; Hohmann AG
    Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Development and Pharmacological Characterization of Selective Blockers of 2-Arachidonoyl Glycerol Degradation with Efficacy in Rodent Models of Multiple Sclerosis and Pain.
    Brindisi M; Maramai S; Gemma S; Brogi S; Grillo A; Di Cesare Mannelli L; Gabellieri E; Lamponi S; Saponara S; Gorelli B; Tedesco D; Bonfiglio T; Landry C; Jung KM; Armirotti A; Luongo L; Ligresti A; Piscitelli F; Bertucci C; Dehouck MP; Campiani G; Maione S; Ghelardini C; Pittaluga A; Piomelli D; Di Marzo V; Butini S
    J Med Chem; 2016 Mar; 59(6):2612-32. PubMed ID: 26888301
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Evaluation of NHS carbamates as a potent and selective class of endocannabinoid hydrolase inhibitors.
    Niphakis MJ; Cognetta AB; Chang JW; Buczynski MW; Parsons LH; Byrne F; Burston JJ; Chapman V; Cravatt BF
    ACS Chem Neurosci; 2013 Sep; 4(9):1322-32. PubMed ID: 23731016
    [TBL] [Abstract][Full Text] [Related]  

  • 120. A reversible and selective inhibitor of monoacylglycerol lipase ameliorates multiple sclerosis.
    Hernández-Torres G; Cipriano M; Hedén E; Björklund E; Canales Á; Zian D; Feliú A; Mecha M; Guaza C; Fowler CJ; Ortega-Gutiérrez S; López-Rodríguez ML
    Angew Chem Int Ed Engl; 2014 Dec; 53(50):13765-70. PubMed ID: 25298214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.